# Ajanta Pharma Ltd. – FDA Inspection, Jun 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/dcc8e789-9501-4bd0-9137-a7594d3fd15c
Source feed: FDA_Inspections

> FDA inspection 1097061 of Ajanta Pharma Ltd., June 28, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097061
- Company Name: Ajanta Pharma Ltd.
- Inspection Date: 2019-06-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1313426 - 2026-04-21](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/6118c3f9-60aa-44a4-ae82-113ff53e50a0)
- FDA Inspection 1235564 - 2024-03-05
- [FDA Inspection 1009806 - 2017-02-07](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/69d66c75-a99f-42cb-bbb1-29c81e157e1a)
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06

## Related Officers

- [Investigator](https://www.keypedia.com/people/jose-a-lopez-rubet/1d1f18e7-bb35-442f-829e-e21b0c081bfa)
- [FDA Associated Person](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)

Company: https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
